Mylan arbitration

There we go. Nice big healthy buy to kick things off. And why wouldn't you at these levels. Any positive outcome from the arbitration with a payout exceeding current annual expenditure ($8mil) plus the daptomycin license back in our hands will see at least a 100% increase in share price (or it should) IMO. I think investors at this level will be ecstatic if that payout is multiples of annual expenditure.